The role of transanal total mesorectal excision in rectal surgery

Abstract

Transanal total mesorectal excision (TaTME) is the newest approach for the resection of rectal cancer, according to the principles of TME. The evolution of TaTME started almost 40 years ago and is a combination of several important developments in both micro-endoscopic surgery and transanal surgery. The preliminary clinical data have revealed acceptable TME quality. Clinical trials to determine the long-term oncological results are still in process. In order to master TaTME, the surgeon should be an expert in laparoscopic rectal surgery as well as transanal microsurgery and follow a stepwise training approach. Robotic TaTME using a single-port robotic system is a promising future development.

Transanal total mesorectal excision: current East Asian perspectives for the future

“…TaTMEs are potential alternatives for East Asian male patients with rectal cancer who have deep and narrow pelvis. Many RCT and prospective studies (especially the RCT in China) are underway that could provide concrete indications for the usefulness and necessity of TaTMEs [41] in East Asia. To further promote TaTMEs in East Asia, further research with East Asian populations and training strategy are necessary.…”

Preface of the special issue on "A bespoke approach to rectal cancer resection and management"

“…Yellinek and Wexner [4] , writing from the Cleveland clinic, discuss an alternative to the robot, namely transanal total mesorectal excision (TaTME), the importance of a registry and training programme though conclude that the single port robot may provide a method for better adopting this technique, potentially as a combined approach and ongoing trial data is awaited. De Nardi [5] suggests that TaTME has comparable functional outcomes compared with the abdominal approach though the COLOR III trial results are eagerly awaited to assess this.…”